PASQUALI, LIVIA
 Distribuzione geografica
Continente #
NA - Nord America 10.278
AS - Asia 5.576
EU - Europa 4.314
SA - Sud America 691
AF - Africa 231
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 2
Totale 21.125
Nazione #
US - Stati Uniti d'America 9.964
SG - Singapore 1.747
CN - Cina 1.739
IT - Italia 1.737
HK - Hong Kong 786
BR - Brasile 580
SE - Svezia 495
DE - Germania 477
VN - Vietnam 406
BG - Bulgaria 318
CA - Canada 261
GB - Regno Unito 256
TR - Turchia 240
FI - Finlandia 200
FR - Francia 183
IN - India 177
UA - Ucraina 160
RU - Federazione Russa 145
AT - Austria 110
JP - Giappone 110
KR - Corea 93
CI - Costa d'Avorio 86
CH - Svizzera 68
BD - Bangladesh 52
AR - Argentina 44
SN - Senegal 44
IQ - Iraq 34
NL - Olanda 33
PL - Polonia 32
MX - Messico 31
ID - Indonesia 25
NG - Nigeria 22
ES - Italia 21
ZA - Sudafrica 21
AU - Australia 19
SA - Arabia Saudita 18
BE - Belgio 16
EC - Ecuador 16
PK - Pakistan 16
UZ - Uzbekistan 16
TW - Taiwan 15
NZ - Nuova Zelanda 14
VE - Venezuela 14
MA - Marocco 13
MY - Malesia 13
EG - Egitto 12
IR - Iran 11
IE - Irlanda 10
CO - Colombia 9
BJ - Benin 8
JO - Giordania 8
LB - Libano 8
LT - Lituania 8
PE - Perù 8
PH - Filippine 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
GR - Grecia 6
KE - Kenya 6
TN - Tunisia 6
HU - Ungheria 5
IL - Israele 5
PA - Panama 5
PS - Palestinian Territory 5
PY - Paraguay 5
TH - Thailandia 5
CL - Cile 4
DK - Danimarca 4
ET - Etiopia 4
KZ - Kazakistan 4
OM - Oman 4
QA - Qatar 4
RS - Serbia 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
LY - Libia 3
ME - Montenegro 3
NP - Nepal 3
PT - Portogallo 3
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
MD - Moldavia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 21.109
Città #
Woodbridge 1.095
Ashburn 964
Singapore 950
Ann Arbor 842
Hong Kong 770
Santa Clara 660
Shanghai 631
Houston 624
Chandler 591
Fairfield 522
San Jose 489
Dallas 470
Serra 458
Sofia 314
Milan 309
Beijing 303
Wilmington 254
New York 240
Seattle 224
Ottawa 205
Jacksonville 201
Cambridge 195
Boardman 174
Izmir 166
Los Angeles 158
Princeton 142
Florence 135
Lawrence 127
Lauterbourg 119
Medford 117
Nanjing 112
Tokyo 100
Vienna 96
Livorno 92
Ho Chi Minh City 87
Abidjan 86
Seoul 85
Hefei 83
Hanoi 74
Des Moines 73
Dong Ket 66
Munich 66
Pisa 66
Rome 64
Nanchang 58
London 55
Bern 54
Helsinki 53
Istanbul 51
Buffalo 50
Redondo Beach 50
Columbus 47
Dearborn 47
The Dalles 46
São Paulo 44
Dakar 43
Frankfurt am Main 43
Bremen 42
Council Bluffs 42
Ogden 41
Jüchen 40
Redwood City 38
Fondi 36
Pune 32
Warsaw 30
Falls Church 29
San Diego 29
Düsseldorf 28
Boulder 27
Rio de Janeiro 27
Turku 26
Orem 25
Shenyang 24
Hebei 23
Hangzhou 22
Kunming 22
Lagos 22
Lancaster 22
Changsha 21
Norwalk 18
Tianjin 18
Chennai 17
Da Nang 17
Phoenix 17
Amsterdam 15
Guangzhou 15
Toronto 15
Baghdad 14
Belo Horizonte 14
Brussels 14
Chicago 14
Detroit 14
Dhaka 14
Stockholm 14
Tashkent 14
Hyderabad 13
Jakarta 13
Jiaxing 13
Nürnberg 13
Washington 13
Totale 15.197
Nome #
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery 362
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modelling of Parkinson’s Disease 356
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 233
The role of mitochondria in stem cell biology 229
Clinical Trials for Neuroprotection in ALS 224
Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine 222
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis 221
Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier 216
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis 216
Gly482Ser PGC-1α gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients 216
Oxidative stress modulation in neurodegenerative diseases 212
The Italian multiple sclerosis register 202
CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. 198
Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 198
Astrocyte-neuron interactions in neurological disorders 197
MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss 195
The Role of Mitochondria in StemCell Biology 193
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic Amyotrophic Lateral Sclerosis 192
Alteration of lactate production during incremental excercise in myotonic dystrophy is not dependent by catecholamine increase 188
Amyotrophic lateral sclerosis with long lasting disease course and SOD1 and TARDBP mutations: Report of two cases and overview of the literature. 188
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 183
Long-term follow-up of 106 multiple sclerosis patients undergoing IFN-ß 1a or 1b therapy: predictive factors of thyroid disease development and duration 182
Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis. 182
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 182
Clinical and demographic features of multiple sclerosis in an Italian register: a cross-sectional ecologic study 181
Occurrence of IgG oligoclonal bands in upper motor neuron disease: just by chance? 181
Sustained wakefulness combined with blood alcohol legal concentrations: effects on car driving performance. 180
A case of comorbidity between multiple sclerosis and multiple system atrophy 180
Impaired oxidative metabolism in exercising muscle from ALS patients. 180
Assessment of endogenous DNA oxidative stress in mitochondrial encephalomyopathies. 179
Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG) 177
Does autophagy worsen or improve the survival of dopaminergic neurons? 177
Metabolic muscle adaptation to aerobic training in patients affected by mitochondrial myopathies. 177
The role of mitochondria in stem cell biology 176
Activation of brain metabolism and fos during limbic seizures: The role of Locus Coeruleus 175
Plasma redox and inflammatory patterns during major depressive episodes: A cross-sectional investigation in elderly patients with mood disorders 175
Lack of α1b-adrenergic receptor protects against epileptic seizures 174
Plasmatic oxidative stress biomarkers in multiple sclerosis patients with different clinical course 174
Subacute Alzheimer’s disease with prominent white matter involvement. Report of a pathologically-confirmed case 174
Predictive factors of thyroid disease during sustained INF-ß therapy in 106 multiple sclerosis patients 173
H-MTTFA muscle levels in mitochondrial myopathies. 172
Plasmatic oxidative stress biomarkers in multiple sclerosis: Relation with clinical and demographic characteristics. 172
Role of autophagy during methamphetamine neurotoxicity 171
Very late onset multiple sclerosis likely associated with restless legs syndrome. A case report. 170
CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy 170
Intracellular pathways underlying the effects of lithium 169
Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies. 169
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 167
Multiple Sclerosis and Neurofibromatosis type1: case report 166
Metabolic and muscle adaptation to aerobic training in CPEO patients. 163
Alpha-synuclein and autophagy as common steps in neurodegeneration 163
Advanced oxidation protein products in serum of patients with myotonic disease type I: association with serum gamma-glutamyltransferase and disease severity 163
Profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis: a clinical and laboratory study. 162
Signs and symptoms of COVID-19 in patients with multiple sclerosis 159
Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine 157
Autophagy, lithium, and amyotrophic lateral sclerosis 156
Facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 155
Facio-scapulo-humeral muscular dystrophy in North-West Tuscany: A clinically and molecularly based epidemiological study 152
Do Thyroid autoimmunity and dysfunction predict clinical outcome of multiple sclerosis patients trated with IFN-β? 151
Spinal cord and parkinsonism: Neuromorphological evidences in humans and experimental studies. 150
Molecular diagnostics and mitochondrial dysfunction: a future perspective 150
Motor neuron pathology and behavioral alterations at late stages in a SMA mouse model. 150
Effects of Alzheimer's disease and mild cognitive impairment on driving ability: a controlled clinical study by simulated driving test 150
Malattie neurologiche in gravidanza 146
Limb girdle muscular dystrophy type 2a associated with epilepsy: a case report. 146
Facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 146
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 146
Miopatie tossiche e da farmaci 144
Parkinson’s disease and the gut: a well known clinical association in need of an effective cure and explanation 144
Cell To Cell Spreading Of Misfolded Proteins As A Therapeutic Target In Motor Neuron Disease. 144
I farmaci inibitori delle colinesterasi nel trattamento dei disturbi psichici e comportamentali nella malattia di Azheimer: focus su galantamina 143
Oxidative stress in myotonic dystrophy type 1 143
MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut 143
Pathways of methamphetamine toxicity 143
H-MTTFA muscle levels in mitochondrial myopathies 142
High number of striatal dopaminergic neurons during early postnatal development: correlation analysis with dopaminergic fibers 142
Gastric emptying in myotonic dystrophic patients. 141
Sensory axonal polyneuropathy in a patient with Systemic capillary leak syndrome (Clarkson disease): a case report. 141
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate. 141
Defining disease pathogenesis by comparative cross-species profiling in human and mouse knock-outs: the downstream consequences of dystrophin deficiency. 139
Effetti psichici e comportamentali dei farmaci antiepilettici nell’adulto 139
Methamphetamine Fails to Alter the Noradrenergic Integrity of the Heart A Comparison with the Parkinsonism-Inducing Neurotoxin MPTP 139
Kennedy’s disease: a case report. 138
Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients 138
Frederich’s ataxia: a case report. 137
Epidemiology of facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based revisitation. 135
PLASMATIC AND CEREBROSPINAL FLUID OXIDATIVE STRESS BIOMARKERS IN ACUTE AND CHRONIC POLYRADICULONEUROPATHIES 135
Cardiomiopatia dilatativa familiare associata a miopatia 134
The importance of nasal resistance in obstructive sleep apnea syndrome: a study with positional rhinomanometry. 134
Lactate production and catecholamine profile during aerobic exercise in normotensive OSAS patients 134
Complicanze gastrointestinali in pazienti neurologici trattati con glucocorticoidi: terapia con gli inibitori di pompa protonica 133
Review of the clinical evidence for interferon beta 1a (Rebif) in the treatment of multiple sclerosis 133
Relation between cerebrospinal fluid oxidative stress biomarkers and intrathecal Ig synthesis in multiple sclerosis 133
Effects of lithium administration on oxidative stress markers in amyotrophic lateral sclerosis patients 133
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 133
Quantitative T1 mapping detects blood-brain barrier breakdown in apparently non-enhancing multiple sclerosis lesions 131
Sudden death in epilepsy: Two case reports 131
Magnetization Transfer Imaging Of Cortical Motor System In Als Patients At Early Stage of Disease 131
Caso clinico: cardiopatia in una portatrice di distrofia muscolare di Duchenne 130
Lithium therapy is able to reduce oxidative stress in amyotrophic lateral sclerosis patients 130
Totale 16.842
Categoria #
all - tutte 55.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021271 0 0 0 0 0 0 0 0 0 66 57 148
2021/20221.425 17 105 19 68 283 196 50 102 78 45 92 370
2022/20232.019 195 248 138 194 228 271 31 145 336 18 192 23
2023/20241.563 184 155 249 112 205 279 60 29 31 53 76 130
2024/20254.888 70 204 41 256 508 441 735 222 435 574 495 907
2025/20264.310 320 522 432 340 557 449 836 206 258 390 0 0
Totale 21.358